Morning Analyst Calls Briefing for Monday, November 21, 2022
Here's a look at new reserch calls for Monday morning, featuring initiations on Intel spin-off Mobileye.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Canadian Natrl Res (CNQ) upgraded to Buy from Neutral at Goldman; tgt raised to $69
> Mueller Water (MWA) upgraded to Buy from Neutral at Northcoast
> On (ONON) upgraded to Buy from Neutral at Goldman; tgt lowered to $28
> Walt Disney (DIS) upgraded to Outperform from Market Perform at MoffettNathanson; tgt $120
Downgrades:
> American Homes 4 Rent (AMH) downgraded to In-line from Outperform at Evercore ISI; tgt lowered to $33
> Aveanna (AVAH) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $3
> Cenovus Energy (CVE) downgraded to Neutral from Buy at Goldman; tgt $23
> Cigna (CI) downgraded to Outperform from Strong Buy at Raymond James; tgt $370
> ConocoPhillips (COP) downgraded to Sell from Hold at Societe Generale; tgt $114
> EverCommerce (EVCM) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $9
> Extra Space Storage (EXR) downgraded to Underperform from In-line at Evercore ISI; tgt lowered to $150
> Federal Signal (FSS) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
> Four Corners Property Trust (FCPT) downgraded to In-line from Outperform at Evercore ISI; tgt $28
> Kimco Realty (KIM) downgraded to In-line from Outperform at Evercore ISI; tgt $22
> MongoDB (MDB) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $215
Others:
> Affiliated Managers (AMG) resumed with a Buy at Goldman; tgt $182
> Apollo Commercial Real Estate (ARI) resumed with a Neutral at BofA Securities; tgt $12
> Cue Biopharma (CUE) initiated with an Overweight at Piper Sandler; tgt $7
> ImmunoGen (IMGN) initiated with a Buy at Truist; tgt $10
> Mersana Therapeutics (MRSN) initiated with a Buy at Truist; tgt $12
> Mobileye Global (MBLY) initiated with a Buy at Citigroup; tgt $77
> Mobileye Global (MBLY) initiated with a Buy at Goldman; tgt $36
> Mobileye Global (MBLY) initiated with a Buy at Mizuho; tgt $35
> Mobileye Global (MBLY) initiated with a Buy at Needham; tgt $40
> Mobileye Global (MBLY) initiated with a Neutral at BofA Securities; tgt $34
> Mobileye Global (MBLY) initiated with a Peer Perform at Wolfe Research
> Mobileye Global (MBLY) initiated with a Strong Buy at Raymond James; tgt $50
> Mobileye Global (MBLY) initiated with an Outperform at Cowen; tgt $35
> Mobileye Global (MBLY) initiated with an Outperform at RBC Capital Mkts; tgt $41
> MongoDB (MDB) initiated with an Overweight at KeyBanc Capital Markets; tgt $215
Research calls posted earlier this morning are available here.
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.